Difference between revisions of "Part:BBa K4414010"
(13 intermediate revisions by 3 users not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K4414010 short</partinfo> | <partinfo>BBa_K4414010 short</partinfo> | ||
− | This basic part consists of the amino-terminal domain (NTD), DNA binding domain (DBD), hinge region and ligand binding domain (LBD)(BBa_K4414000). | + | This basic part consists of the amino-terminal domain (NTD), DNA binding domain (DBD), hinge region and ligand binding domain (LBD)([[Part:BBa_K4414000]])(Weikum, Knuesel, Ortlund, & Yamamoto, 2017). |
==Usage and Biology== | ==Usage and Biology== | ||
− | As glucocorticoid receptor, it can function both as a transcription factor that binds to glucocorticoid response elements (GRE) in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. | + | As glucocorticoid receptor, it can function both as a transcription factor that binds to glucocorticoid response elements (GRE) in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus(Lu & Cidlowski, 2005). We obtained this DNA by PCR amplification from human cDNA.This part can be used in level 1 biological laboratory. |
<html> | <html> | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/ | + | <img src="https://static.igem.wiki/teams/4414/wiki/10-1.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
Line 18: | Line 18: | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/ | + | <img src="https://static.igem.wiki/teams/4414/wiki/10-2.png" class="figure-img img-fluid rounded" height="300px"> |
</figure> | </figure> | ||
</html> | </html> | ||
− | Figure1. Schematic figure of BBa_K4414010 | + | Figure1. Schematic figure of BBa_K4414010. |
Line 29: | Line 29: | ||
<!-- --> | <!-- --> | ||
===Sequence and Features=== | ===Sequence and Features=== | ||
− | <partinfo> | + | <partinfo>BBa_K4414010 SequenceAndFeatures</partinfo> |
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
===Functional Parameters=== | ===Functional Parameters=== | ||
− | <partinfo> | + | <partinfo>BBa_K4414010 parameters</partinfo> |
<!-- --> | <!-- --> | ||
− | |||
==Functional Validation== | ==Functional Validation== | ||
===Method=== | ===Method=== | ||
− | 1. HEK-293T cells were co-transfected with plasmids encoding both | + | 1. HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414010and SEAP with GRE3 or GRE6. Cells were treated with 10, 50, or 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 48 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol(Shao, Qiu, & Xie, 2021). |
− | + | ||
<html> | <html> | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/ | + | <img src="https://static.igem.wiki/teams/4414/wiki/10-3.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
Line 54: | Line 52: | ||
− | 2. HEK-293T cells were transfected with plasmid encoding BBa_K4414010 and BBa_K1123017. Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. The fluorescence intensity of cells was observed 24 h after posting glucocorticoids treatment. | + | 2. HEK-293T cells were transfected with plasmid encoding BBa_K4414010 and ([[Part:BBa_K1123017]]). Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. The fluorescence intensity of cells was observed 24 h after posting glucocorticoids treatment. |
Line 62: | Line 60: | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/ | + | <img src="https://static.igem.wiki/teams/4414/wiki/10-4.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
Line 71: | Line 69: | ||
<figure class="figure"> | <figure class="figure"> | ||
− | <img src="https://static.igem.wiki/teams/4414/wiki/ | + | <img src="https://static.igem.wiki/teams/4414/wiki/10-5.png" class="figure-img img-fluid rounded" height="350px"> |
</figure> | </figure> | ||
</html> | </html> | ||
− | Figure4. Fluorescence intensity of cells mediated by BBa_K4414010 and BBa_K1123017. | + | Figure4. Fluorescence intensity of cells mediated by BBa_K4414010 and ([[Part:BBa_K1123017]]). |
===Reference=== | ===Reference=== | ||
− | + | 1. Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol, 18(3), 159-174. doi:10.1038/nrm.2016.152 | |
− | + | 2. Lu, N. Z., & Cidlowski, J. A. (2005). Translational Regulatory Mechanisms Generate N-Terminal Glucocorticoid Receptor Isoforms with Unique Transcriptional Target Genes. Molecular Cell, 18(3), 331-342. doi:https://doi.org/10.1016/j.molcel.2005.03.025 | |
− | + | 3.Shao, J., Qiu, X., & Xie, M. (2021). Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol, 2312, 35-57. doi:10.1007/978-1-0716-1441-9_3 |
Latest revision as of 03:53, 14 October 2022
NR3C1
This basic part consists of the amino-terminal domain (NTD), DNA binding domain (DBD), hinge region and ligand binding domain (LBD)(Part:BBa_K4414000)(Weikum, Knuesel, Ortlund, & Yamamoto, 2017).
Usage and Biology
As glucocorticoid receptor, it can function both as a transcription factor that binds to glucocorticoid response elements (GRE) in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus(Lu & Cidlowski, 2005). We obtained this DNA by PCR amplification from human cDNA.This part can be used in level 1 biological laboratory. Figure1. Schematic figure of BBa_K4414010.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Functional Validation
Method
1. HEK-293T cells were co-transfected with plasmids encoding both BBa_K4414010and SEAP with GRE3 or GRE6. Cells were treated with 10, 50, or 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 48 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol(Shao, Qiu, & Xie, 2021). Figure 2: Cotransfected our upstream plasmid with the upstream gene and a plasmid with TCE-Tyr into cells
2. HEK-293T cells were transfected with plasmid encoding BBa_K4414010 and (Part:BBa_K1123017). Cells were treated with 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. The fluorescence intensity of cells was observed 24 h after posting glucocorticoids treatment.
Result
Results showed increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (1-2 folds). A dose dependence was observed within 0-100 nM of glucocorticoid (Figure 2). The fluorescence microscopic image showed GR locates in the nucleus whether treated with glucocorticoids or not (Figure 3). Figure3. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414010. Figure4. Fluorescence intensity of cells mediated by BBa_K4414010 and (Part:BBa_K1123017).
Reference
1. Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol, 18(3), 159-174. doi:10.1038/nrm.2016.152
2. Lu, N. Z., & Cidlowski, J. A. (2005). Translational Regulatory Mechanisms Generate N-Terminal Glucocorticoid Receptor Isoforms with Unique Transcriptional Target Genes. Molecular Cell, 18(3), 331-342. doi:https://doi.org/10.1016/j.molcel.2005.03.025
3.Shao, J., Qiu, X., & Xie, M. (2021). Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol, 2312, 35-57. doi:10.1007/978-1-0716-1441-9_3